Charles Schwab’s Contineum Therapeutics CTNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $103K | Sell |
26,039
-25,163
| -49% | -$99.9K | ﹤0.01% | 3415 |
|
|
2025
Q1 | $357K | Sell |
51,202
-4,128
| -7% | -$28.8K | ﹤0.01% | 3167 |
|
|
2024
Q4 | $811K | Buy |
55,330
+12,035
| +28% | +$176K | ﹤0.01% | 2977 |
|
|
2024
Q3 | $829K | Sell |
43,295
-8,477
| -16% | -$162K | ﹤0.01% | 2980 |
|
|
2024
Q2 | $912K | Buy |
+51,772
| New | +$912K | ﹤0.01% | 2972 |
|